Michael J. R. Desborough at Department of Clinical Haematology Oxford University Hospitals NHS Foundation Trust Oxford UK - Research Interests, Publications & Academic Profile

Michael J. R. Desborough

University Name

United Kingdom

Has grant

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do Vietnamese students reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Academic Page

Research Interests

Internal Medicine

20%

Cardiology

30%

Hemostasis

70%

Blood Management

40%

Platelet Biology

30%

Therapeutic Apheresis

30%

Graft-versus-host Disease

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Recent Grants

Grant: Open

Tranexamic acid for hyper acute spontaneous intracerebral haemorrhage TICH-3

Open Date: 2021-05-01

Close Date: 2028-07-31

Grant: Close

Desmopressin for treatment of patients taking Antiplatelet agents with Stroke due to Haemorrhage

Open Date: 2018-06-01

Close Date: 2022-06-30

Articles14

Transfusion Camp: The UK experience and its value in improving knowledge of transfusion medicine among postgraduate trainees.

Article Link

Year:

2024

Desmopressin for prevention of bleeding for thrombocytopenic, critically ill patients undergoing invasive procedures: A randomised, double‐blind, placebo‐controlled feasibility trial

Article Link

Year:

2024

Intravenous iron therapy results in rapid and sustained rise in myocardial iron content through a novel pathway.

Article Link

Year:

2024

Platelet factor XIII-A regulates platelet function and promotes clot retraction and stability

Article Link

Year:

2023

Desmopressin for patients with spontaneous intracerebral haemorrhage taking antiplatelet drugs (DASH): a UK-based, phase 2, randomised, placebo-controlled, multicentre feasibility trial.

Article Link

Year:

2023

Daratumumab for refractory immune‐mediated thrombotic thrombocytopenic purpura

Article Link

Year:

2023

Drug‐induced thrombotic thrombocytopenic purpura: A systematic review and review of European and North American pharmacovigilance data

Article Link

Year:

2023

Antiplatelet Resistance: A Review of Concepts, Mechanisms, and Implications for Management in Acute Ischemic Stroke and Transient Ischemic Attack

Article Link

Year:

2023

Real world reduction in red cell transfusion with restrictive transfusion threshold in haematology inpatients

Article Link

Year:

2023

Haemostatic therapies for stroke due to acute, spontaneous intracerebral haemorrhage.

Article Link

Year:

2023

Platelet transfusion and anticoagulation in haematological cancer-associated thrombosis and thrombocytopenia: the CAVEaT multi-centre prospective cohort.

Article Link

Year:

2022

Pirtobrutinib results in reversible platelet dysfunction compared to ibrutinib and acalabrutinib

Article Link

Year:

2022

Outcomes and management of pregnancy in women with bleeding disorder of unknown cause

Article Link

Year:

2022

Intraoperative cell salvage using swab wash and serial thromboelastography in elective abdominal aortic aneurysm surgery involving massive blood loss.

Article Link

Year:

2022

Collaborators9

Robert Dineen

Professor of Neuroradiology

University of Nottingham

UNITED KINGDOM

Gael B Morrow

University of Aberdeen

UNITED KINGDOM

Claire Whyte

University of Aberdeen

UNITED KINGDOM

Phillip NIcolson

Clinical Lecturer in Haematology

University of Birmingham

UNITED KINGDOM

Sue Pavord

UNITED KINGDOM

Mohammed Altohami

UNITED KINGDOM

Philip Bath

Stroke Association Professor of Stroke Medicine

University of Nottingham

UNITED KINGDOM

Gemma Little

University of Reading

UNITED KINGDOM

Nicola Curry

UNITED KINGDOM

How do Vietnamese students reach out?

Meet Kite AI